Trials / Sponsors / Aminex Therapeutics, Inc.
Aminex Therapeutics, Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer | Phase 1 / Phase 2 | 2026-01-26 |
| Terminated | Oral AMXT 1501 Dicaprate in Combination With IV DFMO Cancer, Solid Tumor, Solid Carcinoma | Phase 1 / Phase 2 | 2022-11-29 |
| Withdrawn | Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers Neoplasms, Medication Toxicity, Tolerance | Phase 1 | 2018-06-12 |
| Completed | Oral AMXT 1501 Dicaprate in Combination With DFMO Cancer, Solid Tumor, Solid Carcinoma | Phase 1 | 2018-06-12 |